BellRing Brands (BRBR) steadies in premarket after 9% slide as law-firm probe adds overhang
30 December 2025
1 min read

BellRing Brands (BRBR) steadies in premarket after 9% slide as law-firm probe adds overhang

NEW YORK, December 30, 2025, 08:01 ET — Premarket

  • BellRing Brands shares were little changed before the open after a steep drop in the prior session.
  • A shareholder law firm said it opened a securities-fraud investigation into the Premier Protein maker.
  • Investors are looking ahead to the company’s next results, estimated for early February.

BellRing Brands Inc shares were down 0.1% in premarket trading on Tuesday at about $27.3, after sliding roughly 9% in the previous session. 1

The move matters because BellRing’s next quarter will be the first full read-through on its fiscal 2026 outlook after a volatile stretch for the stock. Investors are focused on whether demand for convenient nutrition is holding up as retailers manage inventories and promotions.

It also lands at a sensitive moment for the company’s story: how much of its sales momentum comes from consumers buying through at the shelf versus shipments to retailers. That distinction can change how traders model growth and margins.

Bleichmar Fonti & Auld LLP said on Monday it is investigating BellRing for potential violations of federal securities laws. The firm alleged BellRing’s growth may have been boosted by “trade inventory loading” — shipping extra product to retailers to build inventory — rather than sustainable end-consumer demand, according to the release.

On Monday, BRBR opened at $30.15, fell to as low as $26.67 and ended the session at $27.33 on volume of about 4.48 million shares, Investing.com data showed. Traders will be watching whether the stock holds the late-December low near $26.7, with the prior close around $30.2 now acting as a near-term hurdle.

A Form 4 filing on Monday showed director Elliot H. Stein Jr reporting a transaction involving 4,916 shares at a price of $0, described as a transfer and a correction to prior beneficial ownership reporting. 2

The broader market was slightly softer in early trading, with the S&P 500-tracking SPDR ETF down about 0.4% and the Nasdaq 100-tracking QQQ down about 0.5%.

BellRing last reported quarterly results on Nov. 18, when it missed analysts’ earnings-per-share expectations and issued fiscal 2026 revenue guidance of about $2.4 billion to $2.5 billion, MarketBeat data showed. MarketBeat also lists the next earnings date as estimated for Feb. 2, after the market close. 1

In the meantime, investors will watch for any further legal developments tied to the investigation and for any new disclosures in regulatory filings. The next earnings call will also be the next clear chance for management to address retailer inventory trends, promotional intensity and cost pressures in more detail.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Salesforce stock today: CRM ticks up as Fed minutes loom in thin year-end trade
Previous Story

Salesforce stock today: CRM ticks up as Fed minutes loom in thin year-end trade

Nike stock dips today as LSU NIL launch and Total 90 trademark fight keep NKE in focus
Next Story

Nike stock dips today as LSU NIL launch and Total 90 trademark fight keep NKE in focus

Go toTop